Can a new pill slow advanced breast cancer in patients with a key gene mutation?
Disease control
Not yet recruiting
This trial is testing whether adding an experimental drug called JYP0035 to the standard medicine fulvestrant can help people with a certain type of advanced breast cancer. The study focuses on patients whose tumors have a PIK3CA gene mutation and who have already tried hormone t…
Phase 3 • Sponsor: Chengdu JOYO pharma Co., Ltd. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC